Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia.

The gene(s) responsible for natural killer (NK)-cell lymphoma/leukemia have not been identified. In the present study, we found that in NK-cell lymphoma lines (n = 10) and specimens of primary lymphoma (n = 10), levels of miR-21 and miR-155 expression were inversely related and were significantly greater than those found in normal natural killer (CD3(-)CD56(+)) cells (n = 8). To determine the functions of these microRNAs in lymphomagenesis, we examined the effects of antisense oligonucleotides (ASOs) targeting miR-21 (ASO-21) and/or miR-155 (ASO-155) in NK-cell lymphoma lines overexpressing one or both of these miRNAs. Conversely, cells showing little endogenous expression of miR-21 or miR-155 were transduced by the use of lentiviral vectors, leading to their overexpression. Reducing expression of miR-21 or miR-155 led to up-regulation of phosphatase and tensin homologue (PTEN), programmed cell death 4 (PDCD4), or Src homology-2 domain-containing inositol 5-phosphatase 1 (SHIP1). ASO-21- and ASO-155-treated cell lines all showed down-regulation of phosphorylated AKT(ser473). Moreover, transduction with either miR-21 or miR-155 led to down-regulation of PTEN and PDCD4 or SHIP1 with up-regulation of phosphorylated AKT(ser473). Collectively, these results provide important new insight into the pathogenesis of NK-cell lymphoma/leukemia and suggest targeting miR-21 and/or miR-155 may represent a useful approach to treating NK-cell lymphoma/leukemia.

[1]  D. Jong,et al.  Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma , 2007, Oncogene.

[2]  E. Morii,et al.  Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. , 2008, Biochemical and biophysical research communications.

[3]  T. Honjo,et al.  TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). , 1985, Journal of immunology.

[4]  Chunxiang Zhang,et al.  MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation , 2007, Circulation research.

[5]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Chris Sander,et al.  Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. , 2007, Blood.

[7]  M. Lacey,et al.  MicroRNA-155 Is an Epstein-Barr Virus-Induced Gene That Modulates Epstein-Barr Virus-Regulated Gene Expression Pathways , 2008, Journal of Virology.

[8]  Y. Matsuo,et al.  A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation , 2000, Leukemia.

[9]  A. van den Berg,et al.  BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas , 2005, The Journal of pathology.

[10]  J. Mrázek,et al.  Epstein-Barr Virus-Encoded Latent Membrane Protein 1 (LMP1) Induces the Expression of the Cellular MicroRNA miR-146a , 2007, RNA biology.

[11]  Shuji Fujita,et al.  miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. , 2008, Journal of molecular biology.

[12]  P. Boccuni,et al.  Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/TCRγδ+) and DERL-7 (CD56+/CD3−/TCRγδ−), derived from a single patient with CD56+ non-Hodgkin's lymphoma , 2001, Leukemia.

[13]  T. Sawai,et al.  Adhesion of Epstein–Barr virus‐positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines , 2008, Clinical and experimental immunology.

[14]  A. Krogh,et al.  Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[15]  K. Orita,et al.  Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens. , 2002, Leukemia research.

[16]  Morishima,et al.  Characterization of Epstein–Barr virus (EBV)‐infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL‐2‐dependent NK‐like cell line , 1999, Clinical and experimental immunology.

[17]  T. Wurdinger,et al.  MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators , 2008, Molecular and Cellular Biology.

[18]  N. Colburn,et al.  Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. , 2005, Cancer research.

[19]  Danish Sayed,et al.  MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. , 2008, Molecular biology of the cell.

[20]  H. Tagawa,et al.  Genome‐wide array‐based comparative genomic hybridization of natural killer cell lymphoma/leukemia: Different genomic alteration patterns of aggressive NK‐cell leukemia and extranodal Nk/T‐cell lymphoma, nasal type , 2005, Genes, chromosomes & cancer.

[21]  Hugo Naya,et al.  Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis , 2008, Leukemia.

[22]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[23]  N. Colburn,et al.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Mayr,et al.  Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3β signaling and leads to an increased transit time through the G1 phase of the cell cycle , 2004, Leukemia.

[25]  Ryan M. O’Connell,et al.  Inositol phosphatase SHIP1 is a primary target of miR-155 , 2009, Proceedings of the National Academy of Sciences.

[26]  Erik Flemington,et al.  B-cell Receptor Activation Induces BIC/miR-155 Expression through a Conserved AP-1 Element* , 2008, Journal of Biological Chemistry.

[27]  H. Allgayer,et al.  Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors , 2007, Oncogene.

[28]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[29]  J. Chan,et al.  Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia--is there a consistent pattern? , 1999, Leukemia & lymphoma.

[30]  S. Ward,et al.  Evidence That SHIP-1 Contributes to Phosphatidylinositol 3,4,5-Trisphosphate Metabolism in T Lymphocytes and Can Regulate Novel Phosphoinositide 3-Kinase Effectors1 , 2002, The Journal of Immunology.

[31]  W. Rottbauer,et al.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.

[32]  J. Gong,et al.  Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. , 1994, Leukemia.

[33]  A. Rossi,et al.  Epstein–Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway , 2008, Nucleic acids research.

[34]  A. López-Guillermo,et al.  MicroRNA expression profiling in classic Hodgkin lymphoma. , 2008, Blood.

[35]  A. Strasser,et al.  Bim: a novel member of the Bcl‐2 family that promotes apoptosis , 1998, The EMBO journal.

[36]  Y. Kwong,et al.  Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations. , 1999, The American journal of pathology.

[37]  T. Sekine,et al.  Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. , 2001, Blood.

[38]  J. Mrázek,et al.  Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells , 2007, Nucleic acids research.

[39]  Y. Ko,et al.  Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma. , 2001, Cytometry.

[40]  C. Croce,et al.  Epstein-Barr Virus-Induced miR-155 Attenuates NF-κB Signaling and Stabilizes Latent Virus Persistence , 2008, Journal of Virology.

[41]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[42]  Y. Ko,et al.  Deletion Mapping of the Long Arm of Chromosome 6 in Peripheral T and NK Cell Lymphomas , 2003, Leukemia & lymphoma.

[43]  Geert J. P. L. Kops,et al.  The Forkhead Transcription Factor FoxO Regulates Transcription of p27Kip1 and Bim in Response to IL-21 , 2002, The Journal of Immunology.

[44]  M. Seto,et al.  Establishment of an IL‐2‐dependent cell line derived from ‘nasal‐type’ NK/T‐cell lymphoma of CD2+, sCD3−, CD3ɛ+, CD56+ phenotype and associated with the Epstein‐Barr virus , 1998, British journal of haematology.

[45]  Shamit Soneji,et al.  Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma , 2007, International journal of cancer.

[46]  J. Ritz,et al.  Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. , 1996, Experimental hematology.

[47]  Hiroyuki Tagawa,et al.  MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. , 2008, Blood.

[48]  Y. Kwong,et al.  Consistent patterns of allelic loss in natural killer cell lymphoma. , 2000, The American journal of pathology.